Inveready Technology Investment Group — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Aptatargetsaptatargets.comMay 2017 · $3M

aptaTargets develops aptamer-based therapeutics and diagnostics for cerebrovascular diseases, with a lead program (ApTOLL) targeting stroke treatment.

AI & Machine LearningBiotechHealthtechMedical DevicesMadrid, ES

David(Co-Founder & CEO)Maria Eugenia(Co-Founder & CFO)in

Co-investorsCriteria Bio Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.